Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

ESSENTIALS: The role of statins in hemostasis and venous thromboembolism (VTE) prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin generation in patients with VTE. Endogenous thrombin potential and peak were decreased by 10% and 5% with rosuvastatin therapy. These...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsi, Fernanda A., Biedermann, Joseph S., Kruip, Marieke J.H.A., van der Meer, Felix J., Rosendaal, Frits R., van Hylckama Vlieg, Astrid, Bos, Mettine H. A., Leebeek, Frank W. G., Cannegieter, Suzanne C., Lijfering, Willem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
CLINICAL HEMOSTASIS AND THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850636/
https://www.ncbi.nlm.nih.gov/pubmed/30565854
http://dx.doi.org/10.1111/jth.14364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850636/
https://www.ncbi.nlm.nih.gov/pubmed/30565854
http://dx.doi.org/10.1111/jth.14364

Ejemplares similares